Pillar Pacific Capital Management LLC Buys 565 Shares of Roche Holdings AG Basel ADR (OTCMKTS:RHHBY)

Share on StockTwits

Pillar Pacific Capital Management LLC lifted its stake in Roche Holdings AG Basel ADR (OTCMKTS:RHHBY) by 0.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 157,843 shares of the company’s stock after acquiring an additional 565 shares during the period. Pillar Pacific Capital Management LLC’s holdings in Roche Holdings AG Basel were worth $5,558,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of the company. Advisors Asset Management Inc. bought a new stake in Roche Holdings AG Basel during the first quarter valued at $144,000. Beck Mack & Oliver LLC bought a new stake in Roche Holdings AG Basel during the first quarter valued at $203,000. MAI Capital Management bought a new stake in Roche Holdings AG Basel during the first quarter valued at $220,000. Dearborn Partners LLC boosted its stake in Roche Holdings AG Basel by 11.9% during the first quarter. Dearborn Partners LLC now owns 9,339 shares of the company’s stock valued at $321,000 after buying an additional 992 shares during the period. Finally, Boston Private Wealth LLC boosted its stake in Roche Holdings AG Basel by 46.6% during the second quarter. Boston Private Wealth LLC now owns 10,240 shares of the company’s stock valued at $361,000 after buying an additional 3,254 shares during the period. 0.31% of the stock is owned by hedge funds and other institutional investors.

A number of research firms have weighed in on RHHBY. Deutsche Bank upgraded Roche Holdings AG Basel from a “hold” rating to a “buy” rating in a research report on Thursday, June 20th. UBS Group upgraded Roche Holdings AG Basel from a “neutral” rating to a “buy” rating in a research report on Friday, July 26th. Liberum Capital downgraded Roche Holdings AG Basel from a “buy” rating to a “hold” rating in a research report on Thursday, June 20th. Finally, Zacks Investment Research upgraded Roche Holdings AG Basel from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research report on Tuesday, July 9th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus price target of $37.00.

OTCMKTS RHHBY traded down $0.15 during trading hours on Friday, reaching $34.41. 417,591 shares of the stock traded hands, compared to its average volume of 915,873. The stock has a 50 day simple moving average of $34.23 and a two-hundred day simple moving average of $33.94. Roche Holdings AG Basel ADR has a 1 year low of $25.10 and a 1 year high of $35.90. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.40 and a quick ratio of 1.11. The company has a market cap of $236.16 billion, a price-to-earnings ratio of 14.83, a price-to-earnings-growth ratio of 2.23 and a beta of 0.48.

About Roche Holdings AG Basel

Roche Holding AG engages in the diagnostics and prescription pharmaceuticals businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anaemia, anticoagulation therapy, bone, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid and liver disorders, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus and infectious diseases.

Featured Article: How Important is Technical Analysis of Stocks

Institutional Ownership by Quarter for Roche Holdings AG Basel (OTCMKTS:RHHBY)

Receive News & Ratings for Roche Holdings AG Basel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holdings AG Basel and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply